Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes
| Date | 18th, Jan 2022 |
|---|---|
| Source | News Medical - Scientific News Websites |
DESCRIPTION
Individuals living with type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.